Unleash the Mystery of COVID-19 Related Unusual Thrombosis
NCT05068375 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-05-05
Summary
Arterial thrombosis and unusual patterns of thrombotic events in young adults patients with COVID-19 are yet rarely described in this setting and could be underestimated. There is a real need for studies to describe the frequency of unusual thrombotic complications.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Thrombophilia screening
Genetic thrombophilia and acquired thrombophilia screening
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2022-10-15
- Completion
- 2022-10-15
Countries
- Egypt
Study Locations
More Related Trials
-
Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant
NCT05075928 ·Status: UNKNOWN
-
Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome
NCT02562690 ·Status: UNKNOWN
-
Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses
NCT04380779 ·Status: COMPLETED
-
Prediction of Thrombosis Using D-dimer Trends in COVID-19
NCT04827160 ·Status: COMPLETED
-
Collection of the Thrombo-VaxCov Cohort
NCT04889326 ·Status: WITHDRAWN
-
Comparative Study Between Thrombosis Prophylaxis Protocols
NCT00713973 ·Status: COMPLETED
-
Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications
NCT05143567 ·Status: COMPLETED ·Phase: NA
-
Covid-19 Associated Coagulopathy
NCT04360824 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
NCT04400877 ·Status: COMPLETED
-
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
NCT04377997 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19
NCT04736901 ·Status: COMPLETED
-
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
NCT04650087 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
NCT03180567 ·Status: UNKNOWN ·Phase: NA
-
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19
NCT04367662 ·Status: COMPLETED ·Phase: NA
-
Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome
NCT05195372 ·Status: COMPLETED
-
Pharmacogenetics of Warfarin Induction and Inhibition
NCT01447511 ·Status: COMPLETED ·Phase: NA
-
Thromboembolic Complications in Mild Covid-19 Cases
NCT06695377 ·Status: COMPLETED
-
Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome
NCT04597138 ·Status: COMPLETED
-
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
NCT04362085 ·Status: COMPLETED ·Phase: PHASE3
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Practice Variation on Antithrombotics in COVID-19
NCT04998799 ·Status: COMPLETED
-
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
NCT04535128 ·Status: COMPLETED
-
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713 ·Status: RECRUITING ·Phase: PHASE3
-
The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD
NCT05656963 ·Status: UNKNOWN
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3